Paper3915535
ras gene Amplification and malignant transformation.
Pulciani S and 4 others. Mol Cell Biol, 1985. Cited by 232 papers, by iCite.
Cite this record
ConductScience Library. ras gene Amplification and malignant transformation. Papers, record 3915535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3915535
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Viral | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Proto-Oncogenes | Major topic |
| Animals | |
| Cell Transformation, Neoplastic | |
| Cloning, Molecular | |
| Gene Amplification | |
| Gene Expression Regulation | |
| Humans | |
| Mice | |
| Neoplasms | |
| Neoplasms, Experimental | |
| Protein Biosynthesis | |
| Proto-Oncogene Mas | |
| Transcription, Genetic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N01-CO-23909 | NCI NIH HHS | United States | N01CO023909 | PubMed and NIH |
Source NIH RePORTER
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4504350 | Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. | Proc Natl Acad Sci U S A | 1972 | https://conductscience.org/library/papers/4504350 | PubMed |
| 2 | 14243400 | AN UNIDENTIFIED VIRUS WHICH CAUSES THE RAPID PRODUCTION OF TUMOURS IN MICE. | Nature | 1964 | https://conductscience.org/library/papers/14243400 | PubMed |
| 3 | 6154148 | Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus. | J Virol | 1980 | https://conductscience.org/library/papers/6154148 | PubMed |
| 4 | 6159641 | Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6159641 | PubMed |
| 5 | 7233190 | Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. | Science | 1981 | https://conductscience.org/library/papers/7233190 | PubMed |
| 6 | 6265801 | The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. | Nature | 1981 | https://conductscience.org/library/papers/6265801 | PubMed |
| 7 | 6267583 | Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6267583 | PubMed |
| 8 | 6283358 | Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. | Nature | 1982 | https://conductscience.org/library/papers/6283358 | PubMed |
| 9 | 6283384 | T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. | Nature | 1982 | https://conductscience.org/library/papers/6283384 | PubMed |
| 10 | 6286831 | Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. | J Mol Appl Genet | 1982 | https://conductscience.org/library/papers/6286831 | PubMed |
| 11 | 6287003 | Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. | J Virol | 1982 | https://conductscience.org/library/papers/6287003 | PubMed |
| 12 | 6290897 | Mechanism of activation of a human oncogene. | Nature | 1982 | https://conductscience.org/library/papers/6290897 | PubMed |
| 13 | 7133135 | A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. | Nature | 1982 | https://conductscience.org/library/papers/7133135 | PubMed |
| 14 | 7177195 | Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. | Nature | 1982 | https://conductscience.org/library/papers/7177195 | PubMed |
| 15 | 6297003 | Expression of a cellular oncogene during liver regeneration. | Science | 1983 | https://conductscience.org/library/papers/6297003 | PubMed |
| 16 | 6761348 | Transforming genes in human tumors. | J Cell Biochem | 1982 | https://conductscience.org/library/papers/6761348 | PubMed |
| 17 | 6300869 | Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6300869 | PubMed |
| 18 | 6843661 | Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. | Nature | 1983 | https://conductscience.org/library/papers/6843661 | PubMed |
| 19 | 6304530 | A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. | Nature | 1983 | https://conductscience.org/library/papers/6304530 | PubMed |
| 20 | 6308640 | Spontaneous activation of a human proto-oncogene. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6308640 | PubMed |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 232 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42347039 | Boron-Doped Carbon Dots for Organelle Labeling and Mitochondrial Bioimaging. | Methods Protoc | 2026 | https://conductscience.org/library/papers/42347039 | PubMed |
| 40708044 | KRAS amplification in colorectal cancer: correlations with clinicopathological features and prognosis in patients and prediction of response to targeted therapy. | J Transl Med | 2025 | https://conductscience.org/library/papers/40708044 | PubMed |
| 39713985 | Targeting undruggable protein KRAS for cancer therapy: novel opportunities and challenges. | Future Med Chem | 2025 | https://conductscience.org/library/papers/39713985 | PubMed |
| 39711431 | Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification. | Mol Cancer Ther | 2025 | https://conductscience.org/library/papers/39711431 | PubMed |
| 36077614 | DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077614 | PubMed |
| 35216221 | Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216221 | PubMed |
| 34734039 | Olaparib effectively treats local recurrence of extrahepatic cholangiocarcinoma in a patient harboring a BRCA2-inactivating mutation: a case report. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/34734039 | PubMed |
| 30108801 | New tricks for human farnesyltransferase inhibitor: cancer and beyond. | Medchemcomm | 2017 | https://conductscience.org/library/papers/30108801 | PubMed |
| 29808010 | Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. | Nat Med | 2018 | https://conductscience.org/library/papers/29808010 | PubMed |
| 28768863 | HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2. | J Virol | 2017 | https://conductscience.org/library/papers/28768863 | PubMed |
| 27685888 | K-Ras Activation Induces Differential Sensitivity to Sulfur Amino Acid Limitation and Deprivation and to Oxidative and Anti-Oxidative Stress in Mouse Fibroblasts. | PLoS One | 2016 | https://conductscience.org/library/papers/27685888 | PubMed |
| 27409831 | Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study. | Oncotarget | 2016 | https://conductscience.org/library/papers/27409831 | PubMed |
| 26978032 | Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis. | PLoS Genet | 2016 | https://conductscience.org/library/papers/26978032 | PubMed |
| 25776558 | H-ras distribution and signaling in plasma membrane microdomains are regulated by acylation and deacylation events. | Mol Cell Biol | 2015 | https://conductscience.org/library/papers/25776558 | PubMed |
| 25085632 | Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial. | J Hematol Oncol | 2014 | https://conductscience.org/library/papers/25085632 | PubMed |
| 23868065 | Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response. | Cell Death Dis | 2013 | https://conductscience.org/library/papers/23868065 | PubMed |
| 22410778 | Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration. | Oncogene | 2013 | https://conductscience.org/library/papers/22410778 | PubMed |
| 21847114 | Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. | Mol Syst Biol | 2011 | https://conductscience.org/library/papers/21847114 | PubMed |
| 21779504 | Ras in cancer and developmental diseases. | Genes Cancer | 2011 | https://conductscience.org/library/papers/21779504 | PubMed |
| 21779495 | Functional specificity of ras isoforms: so similar but so different. | Genes Cancer | 2011 | https://conductscience.org/library/papers/21779495 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| HRAS | 3265 | PubTator's text mining | https://conductscience.org/library/genes/3265 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3915535
GET https://conductscience.org/api/papers/v1/3915535/references?page=2